Agilent Technologies, Inc. A
172.79
(0.05)
(0.03%)
as of 25 Sep
- Market cap
- $49.0B
- P/E
- 33.9×
Follow A
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Agilent Technologies, Inc. (A) Free cash flow margin
Agilent Technologies, Inc.'s free cash flow margin over the twelve months to 31 July 2026 was 17.2%, up 0.6 percentage points from fiscal 2025 (16.6%). Over the past ten years it has ranged from 10.6% (fiscal 2015) to 21.6% (fiscal 2023); the current reading is higher than 55% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Annual
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 16.6% | (4.51) |
| FY2024 | 21.1% | (0.48) |
| FY2023 | 21.6% | 6.66 |
| FY2022 | 14.9% | (5.62) |
| FY2021 | 20.5% | 5.49 |
| FY2020 | 15.0% | (1.71) |
| FY2019 | 16.8% | (1.79) |
| FY2018 | 18.5% | 2.60 |
| FY2017 | 15.9% | 0.38 |
| FY2016 | 15.6% | 5.01 |
Against its own ten years
Low 10.6%
High 21.6%
Ten-year median
16.6%
Current reading's percentile
55
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 27.2% |
| MTD Mettler-Toledo International, Inc. compare | 20.9% |
| ILMN Illumina, Inc. compare | 20.7% |
| A Agilent Technologies, Inc. | 17.2% |
| IQV IQVIA Holdings Inc. compare | 13.3% |
| DGX Quest Diagnostics Incorporated compare | 11.7% |
| WAT Waters Corporation compare | 7.89% |
| NTRA Natera, Inc. compare | 3.11% |
| GH Guardant Health, Inc. compare | −20.4% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on A
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement